AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimerit-Plus Tablet ER

Prescription Icon
Prescription Required

Marketer

Dr. Ethix's Product & Services Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glimerit-Plus Tablet ER

Diabex Duo ER tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo ER should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and carry a fast-acting glucose source like candy or juice. Alcohol consumption raises hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Diabex Duo ER is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Glimerit-Plus Tablet ER

Managing type 2 diabetes

Major Benefits of Glimerit-Plus Tablet ER:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimerit-Plus Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medicine with food.

Common Side effects of Glimerit-Plus Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimerit-Plus Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimerit-Plus Extended-Release Tablets. Ingest the tablet whole; do not chew, crush, or fracture it. Administer this medication with a meal.

How Glimerit-Plus Tablet ER works:

Glimerit-Plus Extended-Release tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimerit-Plus Extended-Release Tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimerit-Plus Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimerit-Plus tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Extended-release Glimerit-Plus tablets require careful consideration for patients with impaired kidney function. Dosage modification may be necessary; physician consultation is recommended. In cases of severe kidney disease, Glimerit-Plus ER is contraindicated. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimerit-Plus Extended-Release tablets to patients with hepatic impairment. Dosage modification of Glimerit-Plus Extended-Release tablets may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate Glimerit-Plus Extended-Release tablets at a reduced dosage; avoid use in those with severe liver disease.

What if you forget to take Glimerit-Plus Tablet ER :

Should you forget a Glimerit-Plus Tablet ER dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimerit-Plus Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glimerit-Plus Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimerit-Plus Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Stop taking Glimerit-Plus Tablet ER and seek immediate medical attention if you experience these symptoms.
Glimerit-Plus ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimerit-Plus Tablet ER may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimerit-Plus Tablet ER use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimerit-Plus Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimerit-Plus Tablet ER and alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glimerit-Plus Tablet ER
51
MRP 63
18% off